We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,849 hedge funds and large institutions have $266B invested in Johnson & Johnson in 2024 Q1 according to their latest regulatory filings, with 160 funds opening new positions, 1,566 increasing their positions, 1,754 reducing their positions, and 127 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more first-time investments, than exits

New positions opened: 160 | Existing positions closed: 127

19% more call options, than puts

Call options by funds: $2.68B | Put options by funds: $2.25B

1% less funds holding

Funds holding: 3,8703,849 (-21)

1% less capital invested

Capital invested by funds: $269B → $266B (-$3.6B)

1.49% less ownership

Funds ownership: 71.36%69.87% (-1.5%)

11% less repeat investments, than reductions

Existing positions increased: 1,566 | Existing positions reduced: 1,754

31% less funds holding in top 10

Funds holding in top 10: 295204 (-91)

Holders
3,849
Holders Change
-21
Holders Change %
-0.54%
% of All Funds
55.44%
Holding in Top 10
204
Holding in Top 10 Change
-91
Holding in Top 10 Change %
-30.85%
% of All Funds
2.94%
New
160
Increased
1,566
Reduced
1,754
Closed
127
Calls
$2.68B
Puts
$2.25B
Net Calls
+$433M
Net Calls Change
-$85.4M
Name Holding Trade Value Shares
Change
Change in
Stake
FSA
1076
Financial Security Advisor
Virginia
$7.33M -$138K -869 -2%
HBCM
1077
Heron Bay Capital Management
Michigan
$7.32M -$35.3K -222 -0.5%
FNBOO
1078
First National Bank of Omaha
Nebraska
$7.31M -$7.52M -47,259 -52%
TAIM
1079
Te Ahumairangi Investment Management
New Zealand
$7.3M +$210K +1,320 +3%
VST
1080
Van Strum & Towne
California
$7.3M -$53.3K -335 -0.7%
BIA
1081
Barry Investment Advisors
Massachusetts
$7.3M -$125K -785 -2%
DAM
1082
Delta Asset Management
Tennessee
$7.29M -$208K -1,307 -3%
JIR
1083
James Investment Research
Ohio
$7.28M -$272K -1,710 -4%
HEIP
1084
Hudson Edge Investment Partners
New Jersey
$7.27M +$457K +2,870 +7%
PSFG
1085
Prairie Sky Financial Group
Illinois
$7.26M
AAM
1086
Azzad Asset Management
Virginia
$7.25M +$117K +735 +2%
SCA
1087
Stokes Capital Advisors
South Carolina
$7.21M +$571K +3,590 +9%
TIM
1088
Thompson Investment Management
Wisconsin
$7.19M +$79.9K +502 +1%
CIC
1089
Cornercap Investment Counsel
Georgia
$7.19M +$36.8K +231 +0.5%
GAB
1090
German American Bancorp
Indiana
$7.18M +$536K +3,366 +8%
SAM
1091
Smithbridge Asset Management
Pennsylvania
$7.17M +$637 +4 +0%
WA
1092
Wasatch Advisors
Utah
$7.17M
JPWM
1093
Jamison Private Wealth Management
Georgia
$7.17M +$143K +898 +2%
BA
1094
Bristlecone Advisors
Washington
$7.17M +$638K +4,007 +10%
WAS
1095
WESPAC Advisors SoCal
California
$7.14M -$3.49M -21,922 -33%
FFA
1096
First Foundation Advisors
California
$7.12M +$840K +5,279 +13%
PA
1097
Profund Advisors
Maryland
$7.11M -$697K -4,378 -9%
WKWM
1098
Walter & Keenan Wealth Management
Indiana
$7.11M -$26.9K -169 -0.4%
SC
1099
Schulhoff & Co
Ohio
$7.05M -$13.7K -86 -0.2%
NGA
1100
Naples Global Advisors
Florida
$7.03M +$217K +1,363 +3%

JNJ Hedge Fund Activity: Q1 2024 in Review

3,849 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2024, worth a combined $266B — down 1.3% from $269B a quarter earlier.

Buyers outnumbered sellers: 160 funds opened new JNJ positions and 127 closed out — a net gain of 33 holders — while 1,566 added to existing stakes and 1,754 trimmed.

The largest buyer was BlackRock, adding an estimated $544M. The largest seller was Morgan Stanley, cutting an estimated $6.49B.

  • 3,849 institutional investors held Johnson & Johnson (JNJ) as of Q1 2024, down from 3,870 in Q4 2023.
  • Funds reported $266B of Johnson & Johnson stock for Q1 2024, down 1.3% quarter-over-quarter.
  • 160 funds opened new Johnson & Johnson positions in Q1 2024 and 127 closed out, a net change of +33 holders.
  • The largest Johnson & Johnson buyer in Q1 2024 was BlackRock, an estimated $544M added.
  • The largest Johnson & Johnson seller in Q1 2024 was Morgan Stanley, an estimated $6.49B sold.

Based on aggregated 13F filings for Q1 2024.